A patient diagnosed with beta-thalassemia major is being evaluated. Which of the following is characteristic of this condition?

Appeared in: INI-CET EXAM -2026

Explanation

Ineffective hematopoiesis is the hallmark and primary pathophysiological defect in beta-thalassemia major.
It results from an imbalance in globin chain synthesis, where excess alpha-globin chains precipitate in red blood cell precursors within the bone marrow, leading to their premature destruction.
This process is the root cause of the severe anemia characteristic of the disease, as the bone marrow is unable to produce a sufficient number of viable red blood cells.
While other features like iron overload are critical, they are consequences of ineffective hematopoiesis and the subsequent treatment.

Option A: Iron overload is a major complication and a secondary consequence, not the primary defining characteristic. It results from increased intestinal absorption (driven by ineffective hematopoiesis) and the iron load from repeated blood transfusions.
Option B: Leukopoiesis refers to the production of white blood cells. Beta-thalassemia is a disorder of red blood cell production (erythropoiesis).
Option D: In beta-thalassemia, the destruction of red blood cells (hemolysis) is predominantly extravascular, occurring in the spleen and liver as they remove defective red cells. The primary issue in the bone marrow is the destruction of precursors (ineffective hematopoiesis), not intravascular hemolysis.

Clinical Relevance

Nursing practice connection: Use the key finding related to Pathophysiology of Beta-Thalassemia Major to guide bedside assessment, documentation, and the next nursing action.
Understanding that ineffective hematopoiesis is the core problem helps the nurse appreciate why patients have such profound anemia despite a hyperactive bone marrow.
This knowledge underscores the rationale for treatment: blood transfusions to correct the anemia and iron chelation therapy to manage the inevitable iron overload.
Nursing care involves meticulous administration of blood products, monitoring for transfusion reactions, administering iron chelation agents (like deferoxamine), and educating the patient and family about managing this chronic illness.

How to Approach the Question

First, identify the core subject of the question: beta-thalassemia major.
The question asks for a 'characteristic' feature. This requires you to recall the fundamental pathophysiology of the disease.
Analyze the options by differentiating between the primary cause and the secondary effects or complications.
Option C, 'Ineffective hematopoiesis,' describes the primary defect in the bone marrow where red cell precursors are destroyed.
Option A, 'Iron overload,' is a major consequence of the disease and its treatment but not the initial pathological event.
Option D, 'Intravascular hemolysis,' is incorrect because hemolysis in thalassemia is mainly extravascular. Option B is irrelevant.

Concept Tested & Keywords

QAwzMVAgCquiYEuOJB0bSh

E6 Pathology- ROBBINS & COTRAN PATHOLOGIC BASIS OF DISEASE 10TH Ed p. 649-651

E6 PATHOLOGY QUICK REVIEWBased on Harsh Mohan Textbook of PATHOLOGY p. 110-112

Practise the full INI-CET EXAM -2026

Attempt every question from this paper in a timed mock, then review the full solution for each one.